The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I wrote a a sort of interactive review article back in gosh it must have been like 2018 or something I think and um it was it was on the important role of mfsd2a and omega-3 in apoe4 carriers and I have references because I for a lot of the studies like the the deficiency in omega-3 causing one Transporters to go down
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.